Axomove Raises $4.4M in Series A to Scale Digital Rehabilitation Platform

Why It Matters

The capital infusion positions Axomove to become a standard of care in preventive rehabilitation, unlocking sizable cost‑savings for employers and health systems. Its reimbursed, outcomes‑driven model could reshape how musculoskeletal disorders are managed in Europe.

Key Takeaways

• Axomove raised €4M (~$4.3M) Series A to expand platform
• Solution reimbursed by French Social Security for lower back pain
• Clinical data shows double functional capacity and fivefold adherence
• Targets corporate, insurer, provider markets; 75k users across 150 clients

Pulse Analysis

Axomove’s latest Series A round underscores the growing investor appetite for digital therapeutics that tie clinical efficacy to measurable economic benefits. By securing €4 million, the company can scale its evidence‑based platform beyond the current French Social Security reimbursement for lower‑back pain, targeting a broader suite of musculoskeletal and metabolic conditions such as obesity. This expansion aligns with a broader European push to integrate digital health solutions into public insurance schemes, promising lower absenteeism and reduced healthcare spending.

The platform’s hybrid model—combining AI‑driven motion capture, gamified exercises, and professional follow‑up—addresses a long‑standing gap in post‑hospital rehabilitation. Axomove reports that users double their functional capacity and adhere to therapy five times more often than traditional programs, translating into a 50% drop in absenteeism and a threefold reduction in treatment costs. Such outcomes not only improve patient quality of life but also deliver tangible ROI for corporate wellness budgets and insurers seeking to curb chronic musculoskeletal claims.

With a client roster that includes Air France, Thales, Allianz and major French hospitals, Axomove is poised to leverage its 75,000‑user base to refine data analytics and personalize care pathways further. The planned workforce expansion will support R&D into advanced motion‑capture sensors and deeper integration with electronic health records, strengthening its position as a scalable, reimbursable solution across Europe’s fragmented health markets. As digital health reimbursement frameworks mature, Axomove’s model could set a benchmark for how technology-enabled rehabilitation becomes a mainstream, cost‑effective component of preventive care.

Deal Summary

Lille‑based digital health startup Axomove announced a €4 million ($4.4 million) Series A round led by the Digital Prevention Fund (Bpifrance) and Go Capital, with participation from Inco Ventures and Faraday Venture Partners. The funding will accelerate commercial rollout across corporate, insurance and healthcare provider segments, expand reimbursement coverage, and enhance the platform’s technology. The round follows a €1.6 million raise in 2022.